Aged
Aged, 80 and over
Double-Blind Method
Female
Follow-Up Studies
Humans
Macular Degeneration/*therapy
Male
Middle Aged
Plasmapheresis/adverse effects/*methods
Prospective Studies
Treatment Outcome
Visual Acuity/physiology
